Evolva Holding SA
EvoNext Holdings SA is in the process of liquidation of its remaining assets. Previously, the company was engaged in discovery, research, development, and commercialization of nature-based ingredients for use in flavor and fragrances, health ingredients, health protection, and other sectors in Switzerland, the United States, and internationally. The company was formerly known as Evolva Holding SA… Read more
Evolva Holding SA (ELVAF) - Total Liabilities
Latest total liabilities as of December 2024: $945.30K USD
Based on the latest financial reports, Evolva Holding SA (ELVAF) has total liabilities worth $945.30K USD as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Evolva Holding SA - Total Liabilities Trend (2005–2024)
This chart illustrates how Evolva Holding SA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Evolva Holding SA Competitors by Total Liabilities
The table below lists competitors of Evolva Holding SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bioscience Animal Health PCL
BK:BIS
|
Thailand | ฿463.53 Million |
|
Biotron Limited
PINK:BITRF
|
USA | $1.16 Million |
|
Binect AG
XETRA:MA10
|
Germany | €3.31 Million |
|
SE-Education Public Company Limited
BK:SE-ED
|
Thailand | ฿1.28 Billion |
|
Scandium Canada Ltd
PINK:SCDCF
|
USA | $2.11 Million |
|
Pangenomic Health Inc.
F:LL3
|
Germany | €2.04 Million |
|
Plaza Wires Limited
NSE:PLAZACABLE
|
India | ₹509.00 Million |
Liability Composition Analysis (2005–2024)
This chart breaks down Evolva Holding SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Evolva Holding SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Evolva Holding SA (2005–2024)
The table below shows the annual total liabilities of Evolva Holding SA from 2005 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $945.30K | -77.89% |
| 2023-12-31 | $4.28 Million | -82.74% |
| 2022-12-31 | $24.77 Million | +1.50% |
| 2021-12-31 | $24.40 Million | +11.94% |
| 2020-12-31 | $21.80 Million | +11.71% |
| 2019-12-31 | $19.52 Million | +3.50% |
| 2018-12-31 | $18.86 Million | -1.29% |
| 2017-12-31 | $19.10 Million | -24.14% |
| 2016-12-31 | $25.18 Million | -12.64% |
| 2015-12-31 | $28.82 Million | -23.38% |
| 2014-12-31 | $37.62 Million | +71.06% |
| 2013-12-31 | $21.99 Million | -24.52% |
| 2012-12-31 | $29.13 Million | -12.44% |
| 2011-12-31 | $33.27 Million | +50.87% |
| 2010-12-31 | $22.05 Million | -11.65% |
| 2009-12-31 | $24.96 Million | +10.98% |
| 2008-12-31 | $22.49 Million | +15.90% |
| 2007-12-31 | $19.41 Million | +6.18% |
| 2006-12-31 | $18.28 Million | +282.79% |
| 2005-12-31 | $4.77 Million | -- |